Published in J Cell Sci on March 01, 1984
Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction. J Exp Med (2000) 5.02
The osteoclast functional antigen, implicated in the regulation of bone resorption, is biochemically related to the vitronectin receptor. J Cell Biol (1989) 2.27
Generation of osteoclast-inductive and osteoclastogenic cell lines from the H-2KbtsA58 transgenic mouse. Proc Natl Acad Sci U S A (1993) 1.80
The effects of combined micron-/submicron-scale surface roughness and nanoscale features on cell proliferation and differentiation. Biomaterials (2011) 1.79
The pathobiology of the osteoclast. J Clin Pathol (1985) 1.48
Interleukin 18 inhibits osteoclast formation via T cell production of granulocyte macrophage colony-stimulating factor. J Clin Invest (1998) 1.44
Bisphosphonates inhibit the adhesion of breast cancer cells to bone matrices in vitro. J Clin Invest (1996) 1.44
The origin and nature of stromal osteoclast-like multinucleated giant cells in breast carcinoma: implications for tumour osteolysis and macrophage biology. Br J Cancer (1989) 1.42
Human osteoclast formation and bone resorption by monocytes and synovial macrophages in rheumatoid arthritis. Ann Rheum Dis (1996) 1.35
FoxO proteins restrain osteoclastogenesis and bone resorption by attenuating H2O2 accumulation. Nat Commun (2014) 1.23
High levels of tumor necrosis factor-alpha contribute to accelerated loss of cartilage in diabetic fracture healing. Am J Pathol (2009) 1.20
Peptides from the calcitonin genes: molecular genetics, structure and function. Biochem J (1988) 1.14
Endothelin-1 from prostate cancer cells is enhanced by bone contact which blocks osteoclastic bone resorption. Br J Cancer (2000) 1.09
Study of the cell biology and biochemistry of cherubism. J Clin Pathol (1998) 1.09
1,25-Dihydroxyvitamin D3 stimulates rat osteoblastic cells to release a soluble factor that increases osteoclastic bone resorption. J Clin Invest (1987) 1.08
Rab3D regulates a novel vesicular trafficking pathway that is required for osteoclastic bone resorption. Mol Cell Biol (2005) 1.08
Intracellular regulation of enzyme secretion from rat osteoclasts and evidence for a functional role in bone resorption. J Physiol (1990) 1.03
Vitronectin receptor has a role in bone resorption but does not mediate tight sealing zone attachment of osteoclasts to the bone surface. J Cell Biol (1991) 1.02
Osteoclast-like cells form in long-term human bone marrow but not in peripheral blood cultures. J Clin Invest (1989) 1.00
Echistatin is a potent inhibitor of bone resorption in culture. J Cell Biol (1990) 1.00
Bone resorption by macrophage polykaryons of giant cell tumour of tendon sheath. Br J Cancer (1991) 0.99
Implant osseointegration and the role of microroughness and nanostructures: lessons for spine implants. Acta Biomater (2014) 0.97
Arthroplasty implant biomaterial particle associated macrophages differentiate into lacunar bone resorbing cells. Ann Rheum Dis (1996) 0.97
Mode of action of interleukin-6 on mature osteoclasts. Novel interactions with extracellular Ca2+ sensing in the regulation of osteoclastic bone resorption. J Cell Biol (1998) 0.96
Bone resorption by cells isolated from rheumatoid synovium. Ann Rheum Dis (1992) 0.94
Endostatin inhibits VEGF-A induced osteoclastic bone resorption in vitro. BMC Musculoskelet Disord (2006) 0.94
Human fetal osteoclasts fail to express macrophage antigens. Br J Exp Pathol (1985) 0.94
Low-energy irradiation stimulates formation of osteoclast-like cells via RANK expression in vitro. Lasers Med Sci (2006) 0.91
Human osteoclast-specific antigens are expressed by osteoclasts in a wide range of non-human species. Br J Exp Pathol (1986) 0.91
Structure-activity relationship of human calcitonin-gene-related peptide. Biochem J (1990) 0.90
The role of macrophages and giant cells in loosening of joint replacement. Arch Orthop Trauma Surg (1988) 0.89
Connexin-mimetic peptide Gap 27 decreases osteoclastic activity. BMC Musculoskelet Disord (2001) 0.88
CD38/ADP-ribosyl cyclase: A new role in the regulation of osteoclastic bone resorption. J Cell Biol (1999) 0.87
Role of Na-H exchangers and vacuolar H+ pumps in intracellular pH regulation in neonatal rat osteoclasts. J Gen Physiol (1995) 0.86
Membrane trafficking in osteoblasts and osteoclasts: new avenues for understanding and treating skeletal diseases. Traffic (2012) 0.86
Increased resorptive activity and accompanying morphological alterations in osteoclasts derived from the oim/oim mouse model of osteogenesis imperfecta. J Cell Biochem (2007) 0.85
Serum calcium-decreasing factor, caldecrin, inhibits osteoclast differentiation by suppression of NFATc1 activity. J Biol Chem (2010) 0.85
The cytoskeletal framework of chick osteoclasts in resin-less sections. J Anat (1994) 0.85
Human tumour-associated macrophages are capable of bone resorption. Br J Cancer (1992) 0.82
Effects of osteoprotegerin from transfection of pcDNA3.1(+)/chOPG on bioactivity of chicken osteoclasts. Acta Vet Scand (2011) 0.82
Improved methods for testing antiresorptive compounds in human osteoclast cultures. J Bone Miner Metab (2008) 0.82
Bone is not essential for osteoclast activation. PLoS One (2010) 0.81
Osteoprotegerin. Ann Rheum Dis (2001) 0.81
Estrogens and Androgens in Skeletal Physiology and Pathophysiology. Physiol Rev (2017) 0.81
Bisphosphonates in bone cement inhibit PMMA particle induced bone resorption. Ann Rheum Dis (1998) 0.79
Generation and culture of osteoclasts. Bonekey Rep (2014) 0.79
An assessment of the ability of human bone marrow cultures to generate osteoclasts. Int J Exp Pathol (1992) 0.77
The role of 1,25-dihydroxycholecalciferol and prostaglandin E2 in the regulation of human osteoclastic bone resorption in vitro. Int J Exp Pathol (1995) 0.76
Periodontal Ligament and Alveolar Bone in Health and Adaptation: Tooth Movement. Front Oral Biol (2015) 0.75
Influence of acid treatment on surface properties and in vivo performance of Ti6Al4V alloy for biomedical applications. J Mater Sci Mater Med (2017) 0.75
Staphylococcus Aureus Induces Osteoclastogenesis via the NF-κB Signaling Pathway. Med Sci Monit (2017) 0.75
Osteoarthritis cartilage histopathology: grading and staging. Osteoarthritis Cartilage (2005) 6.77
Transcription of infectious yellow fever RNA from full-length cDNA templates produced by in vitro ligation. New Biol (1989) 4.46
TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts. J Exp Med (1998) 2.68
Tumor necrosis factors alpha and beta induce osteoblastic cells to stimulate osteoclastic bone resorption. J Immunol (1987) 2.59
Cleavage at a novel site in the NS4A region by the yellow fever virus NS2B-3 proteinase is a prerequisite for processing at the downstream 4A/4B signalase site. J Virol (1993) 2.56
Monoclonal antibodies to osteoclastomas (giant cell bone tumors): definition of osteoclast-specific cellular antigens. Cancer Res (1985) 2.42
A comparative study by morphometry of the microvasculature in normal and rheumatoid synovium. Arthritis Rheum (1991) 2.18
Colitis causes bone loss in rats through suppression of bone formation. Gastroenterology (1996) 2.09
Rate and pattern of epithelial cell proliferation in ulcerative colitis. Gut (1981) 2.08
Calcitonin alters behaviour of isolated osteoclasts. J Pathol (1982) 2.06
Multinucleate giant cells. J Pathol (1978) 2.04
Colonic adenomas--a colonoscopy survey. Gut (1979) 2.01
Fosl1 is a transcriptional target of c-Fos during osteoclast differentiation. Nat Genet (2000) 1.96
Interleukin-6 and interleukin-11 support human osteoclast formation by a RANKL-independent mechanism. Bone (2003) 1.93
The human osteoclast precursor circulates in the monocyte fraction. Endocrinology (1996) 1.89
The pathology of bone allograft. J Bone Joint Surg Br (1999) 1.87
Osteoclast formation and activity in the pathogenesis of osteoporosis in rheumatoid arthritis. Rheumatology (Oxford) (2002) 1.87
Mutagenesis of the N-linked glycosylation sites of the yellow fever virus NS1 protein: effects on virus replication and mouse neurovirulence. Virology (1996) 1.87
Recombinant chimeric yellow fever-dengue type 2 virus is immunogenic and protective in nonhuman primates. J Virol (2000) 1.79
The pathology of frozen shoulder. J Bone Joint Surg Br (2007) 1.77
Histomorphometry of bone. J Clin Pathol (1983) 1.71
Mutagenesis of conserved residues at the yellow fever virus 3/4A and 4B/5 dibasic cleavage sites: effects on cleavage efficiency and polyprotein processing. Virology (1993) 1.70
Pathology of the torn rotator cuff tendon. Reduction in potential for repair as tear size increases. J Bone Joint Surg Br (2006) 1.69
Osteoclast differentiation from circulating mononuclear precursors in Paget's disease is hypersensitive to 1,25-dihydroxyvitamin D(3) and RANKL. Bone (2000) 1.66
Osteonecrosis in retrieved femoral heads after failed resurfacing arthroplasty of the hip. J Bone Joint Surg Br (2005) 1.66
Avascular necrosis associated with fracture of the femoral neck after hip resurfacing: histological assessment of femoral bone from retrieval specimens. J Bone Joint Surg Br (2010) 1.65
The production and biology of polyethylene wear debris. Arch Orthop Trauma Surg (1978) 1.65
Radio-opaque agents in bone cement increase bone resorption. J Bone Joint Surg Br (1997) 1.63
Mutagenesis of the yellow fever virus NS2A/2B cleavage site: effects on proteolytic processing, viral replication, and evidence for alternative processing of the NS2A protein. Virology (1994) 1.63
Macrophage colony-stimulating factor stimulates survival and chemotactic behavior in isolated osteoclasts. J Exp Med (1993) 1.63
Synovial pathology in Behcet's syndrome. Ann Rheum Dis (1978) 1.54
The granuloma in Crohn's disease. Gut (1979) 1.54
Cellular and hormonal mechanisms associated with malignant bone resorption. Lab Invest (1994) 1.53
Osteoblastic cells mediate osteoclastic responsiveness to parathyroid hormone. Endocrinology (1986) 1.52
Osteoblasts mediate interleukin 1 stimulation of bone resorption by rat osteoclasts. J Exp Med (1986) 1.50
Mycobacterial meningomyelitis associated with human immunodeficiency virus infection. Arch Neurol (1988) 1.49
Substance P-, calcitonin gene-related peptide- and C-flanking peptide of neuropeptide Y-immunoreactive fibres are present in normal synovium but depleted in patients with rheumatoid arthritis. Neuroscience (1990) 1.49
The pathobiology of the osteoclast. J Clin Pathol (1985) 1.48
A role for TGFbeta(1) in osteoclast differentiation and survival. J Cell Sci (2000) 1.47
Necrotic granulomatous pseudotumours in bilateral resurfacing hip arthoplasties: evidence for a type IV immune response. Virchows Arch (2008) 1.46
Calcitonin receptors as markers for osteoclastic differentiation: correlation between generation of bone-resorptive cells and cells that express calcitonin receptors in mouse bone marrow cultures. Endocrinology (1989) 1.44
Failure of cells of the mononuclear phagocyte series to resorb bone. Calcif Tissue Int (1984) 1.43
Macrophage colony stimulating factor (M-CSF) is essential for osteoclast formation in vitro. Biochem Biophys Res Commun (1991) 1.43
Gallium inhibits bone resorption by a direct effect on osteoclasts. Bone Miner (1990) 1.42
A comparative study on the in vivo behavior of hydroxyapatite and silicon substituted hydroxyapatite granules. J Mater Sci Mater Med (2002) 1.42
Sensitivity to titanium. A cause of implant failure? J Bone Joint Surg Br (1991) 1.39
The cellular basis of bone resorption. Clin Orthop Relat Res (1980) 1.38
Bone formation and bone resorption in failed total joint arthroplasties: histomorphometric analysis with histochemical and immunohistochemical technique. J Orthop Res (1996) 1.38
Osteoblast-like cells in the presence of parathyroid hormone release soluble factor that stimulates osteoclastic bone resorption. Endocrinology (1986) 1.37
The effect of calcium-regulating hormones and prostaglandins on bone resorption by osteoclasts disaggregated from neonatal rabbit bones. Endocrinology (1985) 1.35
Human osteoclast formation and bone resorption by monocytes and synovial macrophages in rheumatoid arthritis. Ann Rheum Dis (1996) 1.35
The multinucleate cells in giant cell granulomas of the jaw are osteoclasts. Cancer (1988) 1.34
Cellular and humoral mechanisms of osteoclast formation and bone resorption in Gorham-Stout disease. J Pathol (2001) 1.33
Mononuclear phagocytes of normal and rheumatoid synovial membrane identified by monoclonal antibodies. Immunology (1985) 1.33
Histological and microbiological findings in non-infected and infected revision arthroplasty tissues. The OSIRIS Collaborative Study Group. Oxford Skeletal Infection Research and Intervention Service. Arch Orthop Trauma Surg (2000) 1.32
Molecular basis for attenuation of neurovirulence of a yellow fever Virus/Japanese encephalitis virus chimera vaccine (ChimeriVax-JE). J Virol (2001) 1.32
The composition of normal and osteoarthritic articular cartilage from human knee joints. With special reference to unicompartmental replacement and osteotomy of the knee. J Bone Joint Surg Am (1984) 1.32
An immunohistological study of giant-cell tumour of bone: evidence for an osteoclast origin of the giant cells. J Pathol (1985) 1.31
Histopathology of the synovial membrane of peripheral joints in ankylosing spondylitis. Ann Rheum Dis (1982) 1.31
Apoptosis--a significant cause of bone cell death in osteonecrosis of the femoral head. J Bone Joint Surg Br (2004) 1.29
Cell surface characterization of the human osteoclast: phenotypic relationship to other bone marrow-derived cell types. J Pathol (1984) 1.28
The myocardium in ankylosing spondylitis. A clinical, echocardiographic, and histopathological study. Lancet (1987) 1.27
An assessment of the histological criteria used to diagnose infection in hip revision arthroplasty tissues. J Clin Pathol (1999) 1.26
Induction of NO and prostaglandin E2 in osteoblasts by wall-shear stress but not mechanical strain. Am J Physiol (1997) 1.26
Recent advances in osteoclast biology and pathological bone resorption. Histol Histopathol (2004) 1.25
Features of synovial membrane identified with monoclonal antibodies. Clin Exp Immunol (1985) 1.25
Giant-cell tumour of the tendon sheath in the foot and ankle. J Bone Joint Surg Br (2002) 1.24
Molecular characterization of a repeat element causing large-scale size variation in the mitochondrial DNA of the sea scallop Placopecten magellanicus. Mol Biol Evol (1990) 1.24
Bilateral avascular necrosis of the capitate. A case report and a review of the literature. J Bone Joint Surg Br (1984) 1.24
Dichloromethylenebisphosphonate (Cl2MBP) inhibits bone resorption through injury to osteoclasts that resorb Cl2MBP-coated bone. Bone Miner (1989) 1.23
Immunophenotype of multinucleated and mononuclear cells in giant cell lesions of bone and soft tissue. J Clin Pathol (1992) 1.23
The effects of calcium regulating hormones on bone resorption by isolated human osteoclastoma cells. J Pathol (1985) 1.23
Proliferative activity of cells in the synovium as demonstrated by a monoclonal antibody, Ki67. Rheumatol Int (1987) 1.22
A role for IL-1 alpha in inducing pathologic inflammation during bacterial infection. Proc Natl Acad Sci U S A (2001) 1.22
Aberrant prostaglandin synthase 2 expression defines an antigen-presenting cell defect for insulin-dependent diabetes mellitus. J Clin Invest (1999) 1.21
A comparison of bone mineral density between Caucasian, Asian and Afro-Caribbean women. Clin Sci (Lond) (1994) 1.19
Osteoclasts contain macrophage and megakaryocyte antigens. J Pathol (1986) 1.19
Human arthroplasty derived macrophages differentiate into osteoclastic bone resorbing cells. Ann Rheum Dis (1997) 1.18
An immunohistological study of cartilage and synovium in primary synovial chondromatosis. J Pathol (1992) 1.17
Hypoxia-inducible factor is expressed in giant cell tumour of bone and mediates paracrine effects of hypoxia on monocyte-osteoclast differentiation via induction of VEGF. J Pathol (2008) 1.17
Tumor necrosis factor-alpha mediates osteopenia caused by depletion of antioxidants. Endocrinology (2004) 1.16
Protective effects of hsp70 in inflammation. Experientia (1994) 1.16
Activin A is an essential cofactor for osteoclast induction. Biochem Biophys Res Commun (2000) 1.16
Synovial fluid macrophages are capable of osteoclast formation and resorption. J Pathol (2006) 1.15
Increased insulin-like growth factor I mRNA expression in rat osteocytes in response to mechanical stimulation. Am J Physiol (1995) 1.15
Replication of yellow fever virus in the mouse central nervous system: comparison of neuroadapted and non-neuroadapted virus and partial sequence analysis of the neuroadapted strain. J Gen Virol (1996) 1.15
Proteoglycans of the intervertebral disc. Homology of structure with laryngeal proteoglycans. Biochem J (1979) 1.15
The management of diffuse-type giant cell tumour (pigmented villonodular synovitis) and giant cell tumour of tendon sheath (nodular tenosynovitis). J Bone Joint Surg Br (2012) 1.14
Examination of synovial fluid. Curr Top Pathol (1982) 1.14
Effects of peptides from the calcitonin genes on bone and bone cells. Q J Exp Physiol (1988) 1.14
Multiple Symmetrical Lipomatosis--a mitochondrial disorder of brown fat. Mitochondrion (2013) 1.13
Hydrogels as an interface between bone and an implant. Biomaterials (1993) 1.13
Human macrophage colony-stimulating factor inhibits bone resorption by osteoclasts disaggregated from rat bone. J Cell Physiol (1988) 1.13